Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APC Power and PPI Dose for Barrett's Esophagus
NCT04154748Completed
- Sponsor
- Maria Skłodowska-Curie National Research Institute of Oncology
- Start
- Jun 2002
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of omeprazole in Barrett's esophagus (3 arms), sponsored by Maria Skłodowska-Curie National Research Institute of Oncology. Primary endpoint: Complete ablation rate at 6 weeks. Started Jun 2002; status: completed.
02
Drugs
omeprazole
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT04154748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04154748.